phenoxybenzamine has been researched along with thromboxane a2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Welch, WJ; Wilcox, CS | 1 |
| Dusting, GJ; Li, DM | 1 |
| Black, JW; Saxena, PR; Shankley, NP; Van der Graaf, PH | 1 |
3 other study(ies) available for phenoxybenzamine and thromboxane a2
| Article | Year |
|---|---|
Thromboxane mediation of the pressor response to infused angiotensin II.
Topics: Angiotensin II; Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Dinoprostone; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Hydrazines; Imidazoles; Infusions, Intravenous; Male; Phenoxybenzamine; Phenylephrine; Pressoreceptors; Rats; Rats, Inbred Strains; Saralasin; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes; Urine | 1990 |
Catecholamine release and potentiation of thromboxane A2 production by nicotine in the greyhound.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Catecholamines; Dioxanes; Dogs; Epinephrine; Female; Heart Rate; Idazoxan; Imidazoles; In Vitro Techniques; Ketanserin; Male; Nicotine; Phenoxybenzamine; Piperidines; Thromboxane A2; Vasoconstriction | 1986 |
Exposure and characterization of the action of noradrenaline at dopamine receptors mediating endothelium-independent relaxation of rat isolated small mesenteric arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetonitriles; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Arginine; Brimonidine Tartrate; Cyclooxygenase Inhibitors; Dopamine; Dopamine Antagonists; In Vitro Techniques; Indomethacin; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Phenoxybenzamine; Prostaglandin Endoperoxides, Synthetic; Quinoxalines; Rats; Rats, Wistar; Receptors, Dopamine; Serotonin Antagonists; Splanchnic Circulation; Thromboxane A2; Vasoconstrictor Agents | 1995 |